| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/19/2011 | CA2420279C Selective androgen receptor modulators and methods of use thereof |
| 07/19/2011 | CA2344169C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/14/2011 | WO2011085198A1 Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph) |
| 07/14/2011 | WO2011085009A2 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof |
| 07/14/2011 | WO2011084548A2 Methods and compositions for detecting recesssive familial fsgs and uses thereof |
| 07/14/2011 | WO2011084452A1 Therapeutic uses of soluble alpha-klotho |
| 07/14/2011 | WO2011082732A1 Sphingosine kinase inhibitors |
| 07/14/2011 | US20110172266 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/14/2011 | US20110172246 1-(2-phenoxymethylphenyl)piperazine compounds |
| 07/14/2011 | US20110172244 Compounds and compositions as modulators of gpr119 activity |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172230 Urea compound or salt thereof |
| 07/14/2011 | US20110172198 TGR5 Modulators And Methods Of Use Thereof |
| 07/14/2011 | US20110172195 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 07/14/2011 | US20110172190 Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172143 Method of modulating cell survival and reagents useful for same |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171318 Methods and compositions for the prevention and treatment of kidney disease |
| 07/14/2011 | US20110171268 Uricase compositions and methods of use |
| 07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 07/14/2011 | CA2785200A1 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof |
| 07/14/2011 | CA2784647A1 Inhibitors of sphingosine kinase |
| 07/14/2011 | CA2783555A1 Therapeutic uses of soluble alpha-klotho |
| 07/13/2011 | EP2343282A1 Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
| 07/13/2011 | EP2343279A1 Fused-ring derivative and medical application of same |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP1984001B1 Fixed-dose association of phytate and zinc |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102123699A Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/13/2011 | CN102120724A 5-amino-4-hydroxy-7-benzyl-8-methylnonanamide derivative, preparation method thereof and application thereof in medicines |
| 07/13/2011 | CN102120045A Probiotics-containing female hygienic product as well as preparation method and application thereof |
| 07/13/2011 | CN102119973A Quality control method for gardenia percolate |
| 07/13/2011 | CN102119934A Application of verbascoside in preparation of medicaments for treating chronic prostatitis |
| 07/13/2011 | CN101637592B Diuresis antibiotic pill |
| 07/13/2011 | CN101282926B S1p3 receptor antagonist |
| 07/13/2011 | CN101166742B Novel lactam compound |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977369 Via 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-(1H-indole-4,7-dione )propenol |
| 07/12/2011 | US7977329 Obesity therapy; using 3-benzoazepine compound |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2431617C 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/12/2011 | CA2362527C A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/07/2011 | WO2011082324A1 Methods for the prevention or treatment of vessel occlusion injury |
| 07/07/2011 | WO2011081841A1 Method of renal repair and regeneration and the treatment of diabetic nephropathy |
| 07/07/2011 | WO2011081253A1 Injectable porous microparticle filler system |
| 07/07/2011 | WO2011081189A1 Anti-iga1 antibody |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011081164A1 Anti-cd27 antibody |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166232 Enhancement of urogenital function |
| 07/07/2011 | US20110166223 Methods of inhibiting fgfr3 signaling |
| 07/07/2011 | US20110166136 Calcium Ion Channel Modulators & Uses Thereof |
| 07/07/2011 | US20110166134 Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease |
| 07/07/2011 | US20110166104 Boron-containing small molecules |
| 07/07/2011 | US20110166103 Boron-containing small molecules |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110165264 Use of cilastatin to reduce nephrotatoxicity of various compounds |
| 07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/07/2011 | US20110165222 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 07/07/2011 | US20110165219 Optimization of alginate encapsulation of islets for transplantation |
| 07/07/2011 | US20110165176 Aldosterone induced vascular elastin production |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | CA2789196A1 Anti-iga1 antibody |
| 07/07/2011 | CA2786280A1 Methods for the prevention or treatment of vessel occlusion injury |
| 07/07/2011 | CA2785964A1 Anti-cd27 antibody |
| 07/06/2011 | EP2341044A1 Cycloalkylamine derivative |
| 07/06/2011 | EP2340823A1 Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions |
| 07/06/2011 | EP2340821A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient |
| 07/06/2011 | EP2340028A1 Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors |
| 07/06/2011 | EP1493734B1 Novel crystal form of 5-hydroxy-1-methylhydantoin |
| 07/06/2011 | CN1814127B Shenbao preparation, its preparing method and quality control method |
| 07/06/2011 | CN102115473A Bis-heterocyclic imidazolyl compounds |
| 07/06/2011 | CN102114233A Famous prescription for treating prostatic hyperplasia |
| 07/06/2011 | CN102114209A Traditional Chinese medicine composition for treating early diabetic nephropathy and preparation method thereof |
| 07/06/2011 | CN102114205A Chinese herbal medicine for treating nephropathy |
| 07/06/2011 | CN102114194A Medicament for treating prostatic disease |
| 07/06/2011 | CN102114172A Traditional Chinese medicine for treating hyperplasia of prostate |
| 07/06/2011 | CN102114163A Traditional Chinese medicine for treating Henoch-Schonlein purpura nephritis |
| 07/06/2011 | CN102114138A Traditional Chinese medicine for treating chronic prostatitis |
| 07/06/2011 | CN102114132A Traditional Chinese medicine for treating diabetic nephropathy |
| 07/06/2011 | CN102114131A Traditional Chinese medicine for treating diabetic nephropathy |
| 07/06/2011 | CN102114122A Traditional Chinese medicine for treating chronic prostatitis |
| 07/06/2011 | CN102114100A Traditional Chinese medicine for treating prostatic hypertrophy |
| 07/06/2011 | CN102114056A Production method of pine pollen tablet for treating prostatic hypertrophy |
| 07/06/2011 | CN102114055A Production method of pine pollen health liquor for treating prostatic hypertrophy |
| 07/06/2011 | CN102114046A Preparation method of oviductus ranae preparation |
| 07/06/2011 | CN102114017A Medicinal composition containing amlodipine and perindopril and application thereof |
| 07/06/2011 | CN102113932A Multifunctional saline-alkaline heat transfer treatment baking bed and preparation method thereof |